Specialist molecular diagnostic company lands in Birmingham

Infectious disease diagnostics company Genetic Signatures has joined the BioHub Birmingham® as the launchpad for a planned further expansion into Europe, the Middle East and Africa. The BioHub is the first physical footprint within the UK and Europe for Genetic Signatures, which already provides the EasyScreen™ range of testing kits to countries in Europe and provides clinical diagnostics … Continue reading “Specialist molecular diagnostic company lands in Birmingham”

Mother to child transmission of COVID-19 infection possible – but rare

SARS-CoV-2, the virus causing the COVID-19 infection, can be transmitted from mother to baby before, during and after childbirth – but such occurrences are rare, a new study reveals. Overall, fewer than two per cent of babies born to mothers with SARS-CoV-2 infection also test positive for the virus, but they are more likely to … Continue reading “Mother to child transmission of COVID-19 infection possible – but rare”

CRCTU-led vaccine study open to immunocompromised teens

For the first time, patients aged 12-17 years and immunocompromised are taking part in research to work out how they respond to COVID-19 vaccination. The OCTAVE study, led from the Universities of Glasgow and Birmingham and run by Birmingham’s Cancer Research UK Clinical Trials Unit recruited adults across 10 sites in the UK from May … Continue reading “CRCTU-led vaccine study open to immunocompromised teens”

New antimicrobial air filters rapidly kill SARS-CoV-2 and other viruses, train tests reveal

Researchers at BHP founder-members the University of Birmingham – working in partnership with firms NitroPep Ltd and Pullman AC – have developed new antimicrobial technology for air filters which can in seconds kill bacteria, fungi and viruses including SARS-CoV-2 – providing a potential solution to prevent the spread of airborne infections. In a study, published … Continue reading “New antimicrobial air filters rapidly kill SARS-CoV-2 and other viruses, train tests reveal”

Funding boost to help improve ovarian cancer survival rates

BHP’s newest member NHS Trust has been given a charity grant of £100,000 to help improve survival rates of women with ovarian cancer. The Pan-Birmingham Gynaecological Cancer Centre, based at SWBH’s City Hospital, is working jointly with University of Cambridge to boost the uptake in genetic testing, especially in Black, Asian and Minority Ethnic communities … Continue reading “Funding boost to help improve ovarian cancer survival rates”